Magrini (Aifa): "Two new vaccines against Covid available from the beginning of 2022"

Nicola Magrini - Aifa General Manager

• Aifa green light for the anti Covid vaccination for children aged 5 to 11

• Covid, Locatelli: with Ema-Aifa ok, vaccines for safe children

• Magrini, Aifa: from 29 November decision on vaccine for children, after Christmas the anti Covid pill

Share

13 December 2021 Nicola Magrini, general manager of Aifa-Agenzia Italiana del Farmaco, regarding the anti Covid vaccines announced: "For the anti Covid vaccines

and

This week's evaluation by Ema (European Medicines Agency - European Medicines Agency, ed.) is expected for the first and then soon for the second. In the first months of next year we could have the availability of these vaccines, it is good that there is a further vaccination offer both for the unjustified skeptics (who must not have any kind of skepticism towards RNA vaccines because they have proved to be safe), but also because they can become easier to use vaccines. In the meantime, we are studying whether to modify the vaccines on the basis of the existing variations. "

"The data show a greater effectiveness of vaccines if changed or interchanged: whoever makes a vaccine different from the first facts, will receive a vaccine that is more effective and calmer from the point of view of safety" said Nicola Magrini. On the 

, he added: "We always look at the data, if we look at two years it is conceivable that we can do an annual booster, but what will happen every semester will depend on the vaccination capacity in the whole world and we must invest in this capacity. vaccination The

it was brought forward to strengthen a protective measure, for March or next summer we are led to think that we can have a better perspective, without being completely free, but more out of this pandemic. This is a serious hypothesis. "On

, Magrini said:" Even in the face of this worrying variant, the Italian situation is better, both for vaccinations and for behavior and the third dose involves a slowdown in the epidemic ". Adding: "Meanwhile, the data seem to confirm that the Omicron variant is rapidly expanding but there is reason to believe that it may be less aggressive" and finally the heterologous vaccination "must be seen with tranquility and safety". It is  

"It is important to vaccinate children, they can have a distinct benefit like other age groups. The vaccine is then able to completely reduce hospitalizations. For adolescents, the vaccine has had some success," Magrini finally told Skytg24.

"There were no serious reactions in the first vaccinated, the 3.3 million examined are very comforting from the point of view of the reactions reported. Myocarditis - he added - is a very rare effect and the risk is considerably higher if one takes Covid, so security is wide and it is known that children tolerate vaccinations very well ".